Varcov »

Rapport Therapeutics shares owned by Varcov

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Varcov from 13F filings

Historical chart of Varcov investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Varcov consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Varcov

Quarter filed Position value Share count Share price at filing
2026-03-31 $484k 16k 31.29

More positions owned by Varcov

Ecovyst (ECVT)
WisdomTree Investments (WT)
Textron (TXT)
Cullen/Frost Bankers (CFR)
Healthcare Rlty Tr Cl A Com (HR)
KAR Auction Services (OPLN)
Freshworks Class A Com (FRSH)
Hub Group Cl A (HUBG)
Ingram Micro Hldg Corp (INGM)
Paylocity Holding Corporation (PCTY)
Resideo Technologies (REZI)
Granite Construction (GVA)
Oscar Health Cl A (OSCR)
Cintas Corporation (CTAS)
Worthington Industries (WOR)

View all positions for Varcov

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Vanguard Capital Management
Polar Capital Holdings
Trv Gp Vi

View all funds holding Rapport Therapeutics